United Kingdom· GB-APID-576711000001106
Edronax 4mg tablets
A reboxetine product containing reboxetine, registered in United Kingdom by Pfizer Ltd. The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Reboxetine is registered in 8 of 19 countries.
Countries holding a registration under ATC N06AX18 (reboxetine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Reboxetine · ATC N06AX18
8 / 19 countries
- Belgiumprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of reboxetine costs, country by country.
Normalised to the WHO defined daily dose (8 mg), the median price runs from $1.04 in Italy to $2.27 in Switzerland — a ×2.2 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Reboxetine · price per daily dose (8 mg)
USD · FX 28 Sept 2026
- CH Switzerland$2.27
- IT Italy$1.04
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Reboxetine
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- N06AX18
- ATC class
- Reboxetine
- Defined daily dose
- 8 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5013457025903
- gtin5415062371527
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for reboxetine.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Reboxetine · interactions on record
19 records
19 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Reboxetine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenEdronax 4 mg TablettPfizer AB
- SpainIRENOR 4 mg COMPRIMIDOSPfizer S.L.
- FinlandEdronaxPfizer Oy
- SwitzerlandEdronax, Tabletten 4 mgPfizer AG
- IrelandEdronax® 4 mg tabletsPfizer Healthcare Ireland Unlimited Company
- PolandEdronaxPfizer Europe MA EEIG
- ItalyEDRONAX*20 cpr 4 mgPFIZER ITALIA Srl
- BelgiumEdronax 4 mgPfizer
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Edronax
- Belgium · Edronax
- Bulgaria · Едронакс
- Germany · Edronax
- Spain · Irenor, Norebox
- Croatia · Edronax
- Ireland · Edronax
- Italy · Edronax
- Luxembourg · Edronax
- Poland · Edronax
- Portugal · Edronax
- Sweden · Edronax
- Slovenia · Edronax
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aed5a697-cd72-40bc-9935-63122713ef27 GET /v1/drugs/aed5a697-cd72-40bc-9935-63122713ef27?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "576711000001106",
"desc": "Edronax 4mg tablets (Pfizer Ltd)",
"form": "Oral tablet",
"vpid": "39703311000001102",
"source": "dmd",
"vtm_id": "777405000",
"strength": "4 mg",
"substance": "Reboxetine",
"ingredient": "Reboxetine mesilate",
"supplier_code": "2082201000001106"
}See everything about reboxetine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.